Glaukos Competitors and Similar CompaniesClear all

Glaukos's competitors and similar companies include Haemonetics, ARTIVION, Livanova and Exactech.
Glaukos
Glaukos
Glaukos is an ophthalmic medical technology and pharmaceutical company that develops therapies for treating glaucoma, corneal disorders, and retinal diseases.
Haemonetics
Haemonetics
Haemonetics is a provider of medical products and solutions.
ARTIVION
ARTIVION
CryoLife is a company engaged in the manufacturing, processing, and distribution of medical devices and implantable human tissues used in cardiac and vascular surgical procedures focused on aortic repair.
Livanova
Livanova
LivaNova is a global medical technology company.
Exactech
Exactech
Exactech is a manufacturer of implants and smart technologies for joint replacement.
Founding Date
Founding Date
1998
Founding Date
1971
Founding Date
1984
Founding Date
2015
Founding Date
1985
Type
Type
Public
Type
Public
Type
Public
Type
Public
Type
Subsidiary
Tags
Locations
Locations
Aliso Viejo, US HQ
Buenos Aires, AR
Heatherton, AU
Sao Paulo, BR
Richmond Hill, CA
San José, CR
Wiesbaden, DE
see more
Locations
Boston, US HQ
North Ryde, AU
Edmonton, CA
Québec, CA
Beijing, CN
Shanghai, CN
Brno, CZ
see more
Locations
Kennesaw, US HQ
Paris, FR
Singapore, SG
Guildford, GB
Austin, US
Locations
London, GB HQ
Dandenong South, AU
Wien, AT
Markham, CA
Bogotá, CO
Helsinki, FI
Helsinki, FI
see more
Locations
Gainesville, US HQ
Castle Hill, AU
Mérignac, FR
Meylan, FR
Kiel, DE
Brescia, IT
Tokyo, JP
see more
Employees
Employees
90716% increase
Employees
3,65721% increase
Employees
1,2009% increase
Employees
2,900
Employees
989
Valuation ($)
Valuation ($)
7.6 b
Valuation ($)
3.7 b
Valuation ($)
1.1 b
Valuation ($)
2.9 b
Valuation ($)
N/A

Financial

Revenue (est.)
Revenue (est.)
$314.7m (FY, 2023)
Revenue (est.)
$1.3b (FY, 2024)
Revenue (est.)
$354m (FY, 2023)
Revenue (est.)
$1.2b (FY, 2023)
Revenue (est.)
N/A
Cost of goods
Cost of goods
$75.6m (FY, 2023)
Cost of goods
$617.5m (FY, 2024)
Cost of goods
$124.8m (FY, 2023)
Cost of goods
$382.3m (FY, 2023)
Cost of goods
N/A
Gross profit
Gross profit
$239.1m (FY, 2023)
Gross profit
$691.5m (FY, 2024)
Gross profit
$229.2m (FY, 2023)
Gross profit
$771.3m (FY, 2023)
Gross profit
N/A
Net income
Net income
($134.7m) (FY, 2023)
Net income
$117.6m (FY, 2024)
Net income
($30.7m) (FY, 2023)
Net income
$17.5m (FY, 2023)
Net income
N/A

Operating

Facility Space Leased, sq. ft.
Facility Space Leased, sq. ft.
318 k (FY, 2022)
Facility Space Leased, sq. ft.
885.4 k (FY, 2023)
Facility Space Leased, sq. ft.
N/A
Facility Space Leased, sq. ft.
N/A
Facility Space Leased, sq. ft.
N/A

Funding

Total funding raised
Total funding raised
$ 115m
Total funding raised
N/A
Total funding raised
$ 1.3m
Total funding raised
N/A
Total funding raised
N/A
For sources of this data, please see the company profile

View Company Profiles

Haemonetics
HQ
Boston, US
Employees
3,657↑ 21% increase

Haemonetics is a provider of medical products and solutions.

View company
ARTIVION
HQ
Kennesaw, US
Employees
1,200↑ 9% increase

CryoLife is a company engaged in the manufacturing, processing, and distribution of medical devices and implantable human tissues used in cardiac and vascular surgical procedures focused on aortic repair.

View company
Livanova
HQ
London, GB
Employees
2,900

LivaNova is a global medical technology company.

View company
Exactech
HQ
Gainesville, US

Exactech is a manufacturer of implants and smart technologies for joint replacement.

View company